Regulus Therapeutics | RGLS - Ebitda



Ebitda Изменить Дата
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Celldex Therapeutics USD -86.34M 13.54M 2025-12
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Immunic USD -22.78M 753K 2024-06
Incyte USD 414.5M 92.42M 2025-12
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Merck USD 8.39B 1.97B 2025-09
Omeros USD -47.96M 7.39M 2023-09
Sanofi EUR 5.66B 3.77B 2025-09
Takeda JPY 448.13B 173.98B 2025-12